在 COVID 疫苗接种时代，用 PET/CT 对乳腺癌进行分期的挑战。
The Challenge of Staging Breast Cancer With PET/CT in the Era of COVID Vaccination.
机构信息
From the Breast Unit.
Department of Nuclear Medicine, Royal Free Hospital.
出版信息
Clin Nucl Med. 2021 Dec 1;46(12):1006-1010. doi: 10.1097/RLU.0000000000003683.
Abstract
We report a case series of biopsy-proven reactive axillary lymph nodes, which were avid on FDG PET/CT in breast cancer patients post COVID-19 vaccination. With 4 cases presenting in a consecutive 10-day period, it became apparent that metabolically active axillary lymphadenopathy is an adverse effect of COVID-19 vaccines, currently being deployed worldwide. This may lead to patients undergoing unnecessary biopsy. We have started taking a COVID-19 vaccine status history before PET/CT. If enlarged/metabolically active axillary nodes are identified in the ipsilateral vaccinated arm, then axillary ultrasound at 4 weeks is suggested.
摘要
我们报告了一系列活检证实的反应性腋窝淋巴结病例，这些病例在 COVID-19 疫苗接种后的乳腺癌患者的 FDG PET/CT 上呈阳性。由于在连续的 10 天内出现了 4 例病例，因此很明显，代谢活跃的腋窝淋巴结病是目前在全球范围内部署的 COVID-19 疫苗的一种不良反应。这可能导致患者接受不必要的活检。我们已经开始在 PET/CT 前询问 COVID-19 疫苗接种史。如果在同侧接种疫苗的手臂中发现腋窝淋巴结肿大/代谢活跃，则建议在 4 周时进行腋窝超声检查。
相似文献
1
The Challenge of Staging Breast Cancer With PET/CT in the Era of COVID Vaccination.在 COVID 疫苗接种时代，用 PET/CT 对乳腺癌进行分期的挑战。
Clin Nucl Med. 2021 Dec 1;46(12):1006-1010. doi: 10.1097/RLU.0000000000003683.
2
FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.COVID-19 疫苗接种后反应性腋窝淋巴结病与转移性乳腺癌腋窝淋巴结病的 FDG PET/CT 影像组学鉴别：一项初步研究。
Eur Radiol. 2022 Sep;32(9):5921-5929. doi: 10.1007/s00330-022-08725-3. Epub 2022 Apr 6.
3
[F]FDG uptake of axillary lymph nodes after COVID-19 vaccination in oncological PET/CT: frequency, intensity, and potential clinical impact.COVID-19 疫苗接种后肿瘤 PET/CT 腋窝淋巴结的 FDG 摄取：频率、强度和潜在的临床影响。
Eur Radiol. 2022 Jan;32(1):508-516. doi: 10.1007/s00330-021-08122-2. Epub 2021 Jun 22.
4
False-Positive Axillary Lymph Nodes on FDG PET/CT Resulting From COVID-19 Immunization.新冠肺炎疫苗接种后 FDG PET/CT 检查假阳性腋窝淋巴结。
Clin Nucl Med. 2021 Dec 1;46(12):1004-1005. doi: 10.1097/RLU.0000000000003657.
5
Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality.乳腺癌患者与接种 COVID-19 疫苗后的腋窝淋巴结特征：每种影像学模式的当前证据概述。
Eur J Radiol. 2022 Jul;152:110334. doi: 10.1016/j.ejrad.2022.110334. Epub 2022 Apr 30.
6
Challenging Axillary Lymph Nodes on PET/CT in Cancer Patients throughout COVID-19 Vaccination Era.在 COVID-19 疫苗接种时代，癌症患者 PET/CT 中挑战性的腋窝淋巴结。
Curr Pharm Des. 2024;30(10):798-806. doi: 10.2174/0113816128246329231016091519.
7
Morphological and Metabolic Criteria of COVID-19 Vaccine Associated Axillary Nodes on 18-Fluorodeouxyglucose PET/CT Imaging in Breast Cancer Patients.COVID-19 疫苗相关腋窝淋巴结在乳腺癌患者 18F-氟脱氧葡萄糖 PET/CT 成像中的形态学和代谢标准。
Asian Pac J Cancer Prev. 2023 Dec 1;24(12):4053-4057. doi: 10.31557/APJCP.2023.24.12.4053.
8
Subdiaphragmatic Lymph Nodes Uptake on 18F-FDG PET/CT After COVID-19 Vaccination in the Thigh.大腿 COVID-19 疫苗接种后 18F-FDG PET/CT 下膈下游离淋巴结摄取。
Clin Nucl Med. 2022 Mar 1;47(3):275-276. doi: 10.1097/RLU.0000000000003941.
9
COVID-19 mRNA Vaccination: Age and Immune Status and Its Association with Axillary Lymph Node PET/CT Uptake.COVID-19 mRNA 疫苗接种：年龄和免疫状态及其与腋窝淋巴结 PET/CT 摄取的关系。
J Nucl Med. 2022 Jan;63(1):134-139. doi: 10.2967/jnumed.121.262194. Epub 2021 Apr 23.
10
Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on F-FDG PET/CT.COVID-19 疫苗接种后 F-FDG PET/CT 显示反应性腋窝淋巴结病。
J Nucl Med Technol. 2021 Sep;49(3):286-287. doi: 10.2967/jnmt.121.262008. Epub 2021 Apr 5.
引用本文的文献
1
Current Role and Future Prospects of Positron Emission Tomography (PET)/Computed Tomography (CT) in the Management of Breast Cancer.正电子发射断层扫描（PET）/计算机断层扫描（CT）在乳腺癌管理中的当前作用和未来前景。
Medicina (Kaunas). 2024 Feb 14;60(2):321. doi: 10.3390/medicina60020321.
2
The systemic impact of different COVID-19 vaccines in 2-[18F] FDG-PET/CT.不同 COVID-19 疫苗在 2-[18F] FDG-PET/CT 中的全身影响。
Sci Rep. 2023 Dec 9;13(1):21838. doi: 10.1038/s41598-023-49376-8.
3
Hypermetabolic Axillary Lymph Nodes Associated with COVID-19 Vaccination in Breast Cancer Management.与新冠疫苗接种相关的乳腺癌管理中代谢亢进的腋窝淋巴结
Mol Imaging Radionucl Ther. 2023 Jun 20;32(2):181-185. doi: 10.4274/mirt.galenos.2023.82712.
4
COVID-19 vaccine related hypermetabolic lymph nodes on PET/CT: Implications of inflammatory findings in cancer imaging.COVID-19 疫苗相关 PET/CT 高代谢淋巴结：癌症影像中炎症表现的意义。
Oncol Res. 2023 Apr 10;31(2):117-124. doi: 10.32604/or.2023.027705. eCollection 2023.
5
Unilateral Axillary Lymphadenopathy in Cancer Patients Post-COVID-19 Vaccination: Review and Case Series.新冠疫苗接种后癌症患者的单侧腋窝淋巴结病：综述与病例系列
Case Rep Oncol. 2023 Apr 6;16(1):188-203. doi: 10.1159/000529913. eCollection 2023 Jan-Dec.
6
Immune Response Related to Lymphadenopathy Post COVID-19 Vaccination.与新冠疫苗接种后淋巴结病相关的免疫反应
Vaccines (Basel). 2023 Mar 17;11(3):696. doi: 10.3390/vaccines11030696.
7
State of the Art in 2022 PET/CT in Breast Cancer: A Review.2022年乳腺癌正电子发射断层显像/计算机断层扫描（PET/CT）的研究现状：综述
J Clin Med. 2023 Jan 27;12(3):968. doi: 10.3390/jcm12030968.
8
Surveillance of gynecologic cancer patients post-COVID-19 vaccine: Are CA-125 levels reliable?新冠疫苗接种后妇科癌症患者的监测：癌抗原125（CA-125）水平可靠吗？
Gynecol Oncol Rep. 2023 Feb;45:101140. doi: 10.1016/j.gore.2023.101140. Epub 2023 Jan 21.
9
COVID-19 Vaccine-Associated Lymphadenopathy in Breast Imaging Recipients: A Review of Literature.乳腺影像检查受检者中与新冠病毒疫苗相关的淋巴结病：文献综述
Cureus. 2022 Jul 14;14(7):e26845. doi: 10.7759/cureus.26845. eCollection 2022 Jul.
10
Mammographic findings of diffuse axillary tail trabecular thickening following immunization with mRNA COVID-19 vaccines: Case series study.接种新型冠状病毒 mRNA 疫苗后乳腺钼靶检查发现腋窝尾部弥漫性小梁增厚：病例系列研究
Radiol Case Rep. 2022 Jun 10;17(8):2841-2849. doi: 10.1016/j.radcr.2022.04.028. eCollection 2022 Aug.
Zotero 插件